# Algeria Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Algeria HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Algeria (DZA)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $345.1M
- Products: 26
- Buyer markets: 27
- Average CAGR: +8.9%
- Global sector size: $315.7B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $194.6B | $19.1M | $78.5B | +2.6% | 21 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $26.4B | $337.7K | $15.2B | -10.7% | 9 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $17.5B | $34.1K | $9.9B | +19.2% | 5 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $8.3B | $12.5K | $9.1B | -1.1% | 2 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $7.6B | $948.6 | $5.8B | +65.3% | 2 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $10.7B | $75.6K | $5.1B | +2.6% | 5 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $6.3B | $116.8K | $4.1B | +6.3% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $7.0B | $4.0K | $3.5B | +0.2% | 4 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.2B | $1.4K | $3.4B | +36.8% | 5 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $2.9B | $29.9K | $2.4B | -0.0% | 4 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $3.4B | $221.5 | $2.2B | +5.4% | 2 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $3.1B | $8.1 | $2.1B | -24.0% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $3.0M | $1.9B | +128.6% | 1 | +0.2% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $3.1B | $36.4K | $1.9B | +18.3% | 2 | +0.0% |
| HS 290220 - Cyclic hydrocarbons: benzene | $2.1B | $3.6M | $1.5B | -5.2% | 2 | +0.2% |
| HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $4.2B | $227.1M | $1.5B | +29.1% | 2 | +4.7% |
| HS 281410 - Ammonia: anhydrous | $2.2B | $44.5M | $1.3B | +3.5% | 2 | +1.9% |
| HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $25.6M | $1.2B | +10.5% | 1 | +2.3% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $85.1 | $981.1M | -1.2% | 1 | +0.0% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $375.5 | $871.2M | -26.8% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $60.3K | $803.2M | +36.2% | 1 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $829.8M | $1.6K | $704.5M | +21.2% | 1 | +0.0% |
| HS 284440 - Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $716.3 | $685.2M | +39.3% | 1 | +0.0% |
| HS 290511 - Alcohols: saturated monohydric, methanol (methyl alcohol) | $787.3M | $13.1M | $672.3M | +7.7% | 1 | +1.7% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $1.2B | $284.2 | $561.1M | -20.1% | 1 | +0.0% |
| HS 290243 - Cyclic hydrocarbons: p-xylene | $1.3B | $8.4M | $510.2M | +50.3% | 1 | +2.4% |

## Best markets

- Switzerland, Liechtenstein (CHE): $31.5B calculated opportunity across 3 products.
- Belgium (BEL): $16.5B calculated opportunity across 4 products.
- Germany (DEU): $14.5B calculated opportunity across 10 products.
- USA, Puerto Rico and US Virgin Islands (USA): $13.1B calculated opportunity across 7 products.
- Italy (ITA): $11.3B calculated opportunity across 4 products.
- France (FRA): $9.2B calculated opportunity across 7 products.
- Canada (CAN): $9.0B calculated opportunity across 6 products.
- Spain (ESP): $7.7B calculated opportunity across 4 products.
- Netherlands (NLD): $7.7B calculated opportunity across 5 products.
- United Kingdom (GBR): $7.6B calculated opportunity across 4 products.
- China (CHN): $5.6B calculated opportunity across 3 products.
- Ireland (IRL): $4.7B calculated opportunity across 3 products.

## Growth stars

- HS 382319: +128.6% average CAGR, $1.9B calculated opportunity.
- HS 293399: +65.3% average CAGR, $5.8B calculated opportunity.
- HS 290243: +50.3% average CAGR, $510.2M calculated opportunity.
- HS 284440: +39.3% average CAGR, $685.2M calculated opportunity.
- HS 300290: +36.8% average CAGR, $3.4B calculated opportunity.
- HS 330290: +36.2% average CAGR, $803.2M calculated opportunity.
- HS 310210: +29.1% average CAGR, $1.5B calculated opportunity.
- HS 382600: +21.2% average CAGR, $704.5M calculated opportunity.
- HS 300212: +19.2% average CAGR, $9.9B calculated opportunity.
- HS 340220: +18.3% average CAGR, $1.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 21 buyer markets, $78.5B calculated opportunity.
- HS 382499: 9 buyer markets, $15.2B calculated opportunity.
- HS 300212: 5 buyer markets, $9.9B calculated opportunity.
- HS 382200: 5 buyer markets, $5.1B calculated opportunity.
- HS 300290: 5 buyer markets, $3.4B calculated opportunity.
- HS 330499: 4 buyer markets, $3.5B calculated opportunity.
- HS 330210: 4 buyer markets, $2.4B calculated opportunity.
- HS 300439: 3 buyer markets, $4.1B calculated opportunity.
- HS 300220: 2 buyer markets, $9.1B calculated opportunity.
- HS 293399: 2 buyer markets, $5.8B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.